Cargando…

Dynamic Changes of the Fungal Microbiome in Alcohol Use Disorder

BACKGROUND: Alcohol-associated liver disease (ALD) is an important cause of morbidity and mortality worldwide. The intestinal microbiota is involved in the development and progression of ALD; however, little is known about commensal fungi therein. METHODS: We studied the dynamic changes of the intes...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hartmann, Phillipp, Lang, Sonja, Zeng, Suling, Duan, Yi, Zhang, Xinlian, Wang, Yanhan, Bondareva, Marina, Kruglov, Andrey, Fouts, Derrick E., Stärkel, Peter, Schnabl, Bernd
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Physiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8327211/ https://www.ncbi.nlm.nih.gov/pubmed/34349667 http://dx.doi.org/10.3389/fphys.2021.699253

Ejemplares similares

Malassezia restricta promotes alcohol-induced liver injury
por: Zeng, Suling, et al.
Publicado: (2023)

Intestinal virome in patients with alcohol use disorder and after abstinence
por: Hsu, Cynthia L., et al.
Publicado: (2022)

Functional Microbial Responses to Alcohol Abstinence in Patients With Alcohol Use Disorder
por: Gao, Bei, et al.
Publicado: (2020)

The intestinal microbiome and the leaky gut as therapeutic targets in alcoholic liver disease
por: Hartmann, Phillipp, et al.
Publicado: (2012)

Changes in the fecal bacterial microbiota associated with disease severity in alcoholic hepatitis patients
por: Lang, Sonja, et al.
Publicado: (2020)

Lipidomics for the Prediction of Progressive Liver Disease in Patients with Alcohol Use Disorder
por: Gao, Bei, et al.
Publicado: (2022)

Machine Learning Applied to Omics Datasets Predicts Mortality in Patients with Alcoholic Hepatitis
por: Gao, Bei, et al.
Publicado: (2022)

Global and national prevalence of nonalcoholic fatty liver disease in adolescents: An analysis of the global burden of disease study 2019
por: Hartmann, Phillipp, et al.
Publicado: (2023)

The gut mycobiome: a novel player in chronic liver diseases
por: Jiang, Lu, et al.
Publicado: (2020)

Integrative Analysis of Metabolome and Microbiome in Patients with Progressive Alcohol-Associated Liver Disease
por: Gao, Bei, et al.
Publicado: (2021)

Intestinal permeability, microbial translocation, changes in duodenal and fecal microbiota, and their associations with alcoholic liver disease progression in humans
por: Maccioni, Luca, et al.
Publicado: (2020)

Editorial: The Microbiome in Hepatobiliary and Intestinal Disease
por: Hartmann, Phillipp
Publicado: (2022)

Functional Microbiomics Reveals Alterations of the Gut Microbiome and Host Co‐Metabolism in Patients With Alcoholic Hepatitis
por: Gao, Bei, et al.
Publicado: (2020)

Fungi–Bacteria Correlation in Alcoholic Hepatitis Patients
por: Gao, Bei, et al.
Publicado: (2021)

Colesevelam ameliorates non-alcoholic steatohepatitis and obesity in mice
por: Hartmann, Phillipp, et al.
Publicado: (2022)

Host Factors in Dysregulation of the Gut Barrier Function during Alcohol-Associated Liver Disease
por: Maccioni, Luca, et al.
Publicado: (2021)

Host-Microbiome Interactions in Alcoholic Liver Disease
por: Chen, Peng, et al.
Publicado: (2014)

Correlation between Serum Steroid Hormones and Gut Microbiota in Patients with Alcohol-Associated Liver Disease
por: Gao, Bei, et al.
Publicado: (2022)

Inexpensive, Accurate, and Stable Method to Quantitate Blood Alanine Aminotransferase (ALT) Levels
por: Hartmann, Phillipp, et al.
Publicado: (2022)

Tumor necrosis factor alpha receptor 1 deficiency in hepatocytes does not protect from non-alcoholic steatohepatitis, but attenuates insulin resistance in mice
por: Bluemel, Sena, et al.
Publicado: (2020)

Interplay Between Microbiota, Toll-Like Receptors and Cytokines for the Maintenance of Epithelial Barrier Integrity
por: Semin, Iaroslav, et al.
Publicado: (2021)

How to calculate sample size in animal and human studies
por: Zhang, Xinlian, et al.
Publicado: (2023)

Toll-like receptor 2 activation in monocytes contributes to systemic inflammation and alcohol-associated liver disease in humans
por: Maccioni, Luca, et al.
Publicado: (2023)

Development of a Quantitative PCR Method for Detecting Enterococcus faecalis Cytolysin in Human Stool Samples
por: Cabré, Noemí, et al.
Publicado: (2023)

CRIg on liver macrophages clears pathobionts and protects against alcoholic liver disease
por: Duan, Yi, et al.
Publicado: (2021)

Opposing Actions of Adrenocorticotropic Hormone and Glucocorticoids on UCP1-Mediated Respiration in Brown Adipocytes
por: Schnabl, Katharina, et al.
Publicado: (2019)

Green Plant Pigment, Chlorophyllin, Ameliorates Non-alcoholic Fatty Liver Diseases (NAFLDs) Through Modulating Gut Microbiome in Mice
por: Yang, You, et al.
Publicado: (2021)

Individualized medicine and the microbiome in reproductive tract
por: Braundmeier, Andrea G., et al.
Publicado: (2015)

Gut dysbiosis as a driver in alcohol-induced liver injury
por: Fairfield, Bradley, et al.
Publicado: (2020)

From intestinal dysbiosis to alcohol-associated liver disease
por: Mendes, Beatriz Garcia, et al.
Publicado: (2020)

Deficient IL‐6/Stat3 Signaling, High TLR7, and Type I Interferons in Early Human Alcoholic Liver Disease: A Triad for Liver Damage and Fibrosis
por: Stärkel, Peter, et al.
Publicado: (2019)

Modeling the Role of the Microbiome in Evolution
por: Huitzil, Saúl, et al.
Publicado: (2018)

Dysbiosis in the Human Microbiome of Cholangiocarcinoma
por: Rao, Benchen, et al.
Publicado: (2021)

Editorial: Gut microbiome and metabolic physiology
por: Ishimwe, Jeanne A., et al.
Publicado: (2023)

Skin wound closure delay in metabolic syndrome correlates with SCF deficiency in keratinocytes
por: Wang, Zhenping, et al.
Publicado: (2020)

Alterations of the Gut Microbiome and Fecal Metabolome in Colorectal Cancer: Implication of Intestinal Metabolism for Tumorigenesis
por: Du, Xinhao, et al.
Publicado: (2022)

Systems approaches to computational modeling of the oral microbiome
por: Dimitrov, Dimiter V.
Publicado: (2013)

The Microbiome-Mitochondria Dance in Prodromal Parkinson’s Disease
por: Cardoso, Sandra M., et al.
Publicado: (2018)

Bacteriophage targeting of gut bacterium attenuates alcoholic liver disease
por: Duan, Yi, et al.
Publicado: (2019)

Extracellular Vesicles in Non-alcoholic Fatty Liver Disease and Alcoholic Liver Disease
por: Wu, Dongqing, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_4g4n90a9uo6ppe4m80rtdu0s5u